A citation-based method for searching scientific literature

Badder Kattih, Amir Shirvani, Piroska Klement, Abel Martin Garrido, Razif Gabdoulline, Alessandro Liebich, Maximilian Brandes, Anuhar Chaturvedi, Timon Seeger, Felicitas Thol, Gudrun Göhring, Brigitte Schlegelberger, Robert Geffers, David John, Udo Bavendiek, Johann Bauersachs, Arnold Ganser, Joerg Heineke, Michael Heuser. Leukemia 2021
Times Cited: 12







List of co-cited articles
63 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli,[...]. N Engl J Med 2016
41

Age-related clonal hematopoiesis associated with adverse outcomes.
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, Alisa Manning, Peter V Grauman, Brenton G Mar, R Coleman Lindsley, Craig H Mermel, Noel Burtt, Alejandro Chavez,[...]. N Engl J Med 2014
25

Clonal hematopoiesis in human aging and disease.
Siddhartha Jaiswal, Benjamin L Ebert. Science 2019
263
25

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, Alice S Mims, Ronan Swords, Robert H Collins, Gabriel N Mannis, Daniel A Pollyea,[...]. N Engl J Med 2018
691
25

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.
Maria E Figueroa, Omar Abdel-Wahab, Chao Lu, Patrick S Ward, Jay Patel, Alan Shih, Yushan Li, Neha Bhagwat, Aparna Vasanthakumar, Hugo F Fernandez,[...]. Cancer Cell 2010
25

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies.
Zhe Li, Xiaoqiang Cai, Chen-Leng Cai, Jiapeng Wang, Wenyong Zhang, Bruce E Petersen, Feng-Chun Yang, Mingjiang Xu. Blood 2011
442
25

Connections Between Clonal Hematopoiesis, Cardiovascular Disease, and Cancer: A Review.
Oscar Calvillo-Argüelles, Siddhartha Jaiswal, Liran I Shlush, Javid J Moslehi, Aaron Schimmer, Ana Barac, Paaladinesh Thavendiranathan. JAMA Cardiol 2019
27
25

Shared Risk Factors in Cardiovascular Disease and Cancer.
Ryan J Koene, Anna E Prizment, Anne Blaes, Suma H Konety. Circulation 2016
542
25

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Lena Dorsheimer, Birgit Assmus, Tina Rasper, Christina A Ortmann, Andreas Ecke, Khalil Abou-El-Ardat, Tobias Schmid, Bernhard Brüne, Sebastian Wagner, Hubert Serve,[...]. JAMA Cardiol 2019
183
25

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
Siddhartha Jaiswal, Pradeep Natarajan, Alexander J Silver, Christopher J Gibson, Alexander G Bick, Eugenia Shvartz, Marie McConkey, Namrata Gupta, Stacey Gabriel, Diego Ardissino,[...]. N Engl J Med 2017
25

Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.
Peter Libby, Robert Sidlow, Amy E Lin, Dipti Gupta, Lee W Jones, Javid Moslehi, Andreas Zeiher, Siddhartha Jaiswal, Christian Schulz, Ron Blankstein,[...]. J Am Coll Cardiol 2019
79
25


Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Daniela Cardinale, Alessandro Colombo, Giulia Bacchiani, Ines Tedeschi, Carlo A Meroni, Fabrizio Veglia, Maurizio Civelli, Giuseppina Lamantia, Nicola Colombo, Giuseppe Curigliano,[...]. Circulation 2015
743
16

A population-based study of cardiovascular disease mortality risk in US cancer patients.
Kathleen M Sturgeon, Lei Deng, Shirley M Bluethmann, Shouhao Zhou, Daniel M Trifiletti, Changchuan Jiang, Scott P Kelly, Nicholas G Zaorsky. Eur Heart J 2019
225
16

Prevalence and prognosis significance of cardiovascular disease in cancer patients: a population-based study.
Dong Liu, Zhiqiang Ma, Jingang Yang, Min Zhao, Huiping Ao, Xiaodong Zheng, Qianfa Wen, Yuejin Yang, Jiangyun You, Shubin Qiao,[...]. Aging (Albany NY) 2019
18
16

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Hartmut Döhner, Elihu Estey, David Grimwade, Sergio Amadori, Frederick R Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Richard A Larson,[...]. Blood 2017
16

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib.
Eytan M Stein, Courtney D DiNardo, Amir T Fathi, Daniel A Pollyea, Richard M Stone, Jessica K Altman, Gail J Roboz, Manish R Patel, Robert Collins, Ian W Flinn,[...]. Blood 2019
181
16

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts.
Hervé Dombret, John F Seymour, Aleksandra Butrym, Agnieszka Wierzbowska, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James Cavenagh, Andre C Schuh, Anna Candoni,[...]. Blood 2015
678
16

Age-related clonal hematopoiesis.
Liran I Shlush. Blood 2018
140
16

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, Michael J Thirman, Jacqueline S Garcia, Andrew H Wei, Marina Konopleva, Hartmut Döhner, Anthony Letai, Pierre Fenaux,[...]. N Engl J Med 2020
542
16

Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial.
Amy Burd, Ross L Levine, Amy S Ruppert, Alice S Mims, Uma Borate, Eytan M Stein, Prapti Patel, Maria R Baer, Wendy Stock, Michael Deininger,[...]. Nat Med 2020
34
16

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
Patrick S Ward, Jay Patel, David R Wise, Omar Abdel-Wahab, Bryson D Bennett, Hilary A Coller, Justin R Cross, Valeria R Fantin, Cyrus V Hedvat, Alexander E Perl,[...]. Cancer Cell 2010
16

Mutation in TET2 in myeloid cancers.
François Delhommeau, Sabrina Dupont, Véronique Della Valle, Chloé James, Severine Trannoy, Aline Massé, Olivier Kosmider, Jean-Pierre Le Couedic, Fabienne Robert, Antonio Alberdi,[...]. N Engl J Med 2009
16

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
Timothy J Ley, Christopher Miller, Li Ding, Benjamin J Raphael, Andrew J Mungall, A Gordon Robertson, Katherine Hoadley, Timothy J Triche, Peter W Laird, Jack D Baty,[...]. N Engl J Med 2013
16

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.
Shinsuke Ito, Ana C D'Alessio, Olena V Taranova, Kwonho Hong, Lawrence C Sowers, Yi Zhang. Nature 2010
16

TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair.
Yimei Feng, Xiaoping Li, Kaniel Cassady, Zhongmin Zou, Xi Zhang. Front Oncol 2019
48
16

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.
Olga A Guryanova, Kaitlyn Shank, Barbara Spitzer, Luisa Luciani, Richard P Koche, Francine E Garrett-Bakelman, Chezi Ganzel, Benjamin H Durham, Abhinita Mohanty, Gregor Hoermann,[...]. Nat Med 2016
137
16

RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
Rabindranath Bera, Ming-Chun Chiu, Ying-Jung Huang, Tung-Huei Lin, Ming-Chung Kuo, Lee-Yung Shih. J Hematol Oncol 2019
16
16

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, S Schnittger, M Sanada, A Kon, T Alpermann,[...]. Leukemia 2014
941
16

(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible.
Julie-Aurore Losman, Ryan E Looper, Peppi Koivunen, Sungwoo Lee, Rebekka K Schneider, Christine McMahon, Glenn S Cowley, David E Root, Benjamin L Ebert, William G Kaelin. Science 2013
494
16

DNMT3A in Leukemia.
Lorenzo Brunetti, Michael C Gundry, Margaret A Goodell. Cold Spring Harb Perspect Med 2017
74
16

Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.
Kelly Moran-Crusio, Linsey Reavie, Alan Shih, Omar Abdel-Wahab, Delphine Ndiaye-Lobry, Camille Lobry, Maria E Figueroa, Aparna Vasanthakumar, Jay Patel, Xinyang Zhao,[...]. Cancer Cell 2011
841
16

Recurring mutations found by sequencing an acute myeloid leukemia genome.
Elaine R Mardis, Li Ding, David J Dooling, David E Larson, Michael D McLellan, Ken Chen, Daniel C Koboldt, Robert S Fulton, Kim D Delehaunty, Sean D McGrath,[...]. N Engl J Med 2009
16

Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.
Anuhar Chaturvedi, Michelle Maria Araujo Cruz, Nidhi Jyotsana, Amit Sharma, Haiyang Yun, Kerstin Görlich, Martin Wichmann, Adrian Schwarzer, Matthias Preller, Felicitas Thol,[...]. Blood 2013
152
16

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
Wei Xu, Hui Yang, Ying Liu, Ying Yang, Ping Wang, Se-Hee Kim, Shinsuke Ito, Chen Yang, Pu Wang, Meng-Tao Xiao,[...]. Cancer Cell 2011
16

Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition.
Chong Chen, Yu Liu, Chao Lu, Justin R Cross, John P Morris, Aditya S Shroff, Patrick S Ward, James E Bradner, Craig Thompson, Scott W Lowe. Genes Dev 2013
141
16

IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors.
Remco J Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, Mohammed Khurshed, Bartolomiej Przychodzen, Hideki Makishima, Mingjiang Xu, Fonnet E Bleeker, Johanna W Wilmink, Hetty E Carraway,[...]. Clin Cancer Res 2018
58
16

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.
Katharine Yen, Jeremy Travins, Fang Wang, Muriel D David, Erin Artin, Kimberly Straley, Anil Padyana, Stefan Gross, Byron DeLaBarre, Erica Tobin,[...]. Cancer Discov 2017
237
16

Prediction of acute myeloid leukaemia risk in healthy individuals.
Sagi Abelson, Grace Collord, Stanley W K Ng, Omer Weissbrod, Netta Mendelson Cohen, Elisabeth Niemeyer, Noam Barda, Philip C Zuzarte, Lawrence Heisler, Yogi Sundaravadanam,[...]. Nature 2018
364
16

Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
Kelly L Bolton, Ryan N Ptashkin, Teng Gao, Lior Braunstein, Sean M Devlin, Daniel Kelly, Minal Patel, Antonin Berthon, Aijazuddin Syed, Mariko Yabe,[...]. Nat Genet 2020
122
16

Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.
Robert L Bowman, Lambert Busque, Ross L Levine. Cell Stem Cell 2018
219
16

Somatic mutations precede acute myeloid leukemia years before diagnosis.
Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov, Michael S Simon, Gloria Cheang, Sangmin Lee, Michael Samuel, Ellen K Ritchie, Monica L Guzman, Karla V Ballman,[...]. Nat Med 2018
266
16

Cardiovascular Risk Factors are Associated with Future Cancer.
Emily S Lau, Samantha M Paniagua, Elizabeth Liu, Manol Jovani, Shawn X Li, Katherine Takvorian, Navin Suthahar, Susan Cheng, Greta L Splansky, James L Januzzi,[...]. JACC CardioOncol 2021
26
16

Heart Failure Stimulates Tumor Growth by Circulating Factors.
Wouter C Meijers, Manuel Maglione, Stephan J L Bakker, Rupert Oberhuber, Lyanne M Kieneker, Steven de Jong, Bernhard J Haubner, Wouter B Nagengast, Alexander R Lyon, Bert van der Vegt,[...]. Circulation 2018
131
16

Cancer cachexia: understanding the molecular basis.
Josep M Argilés, Sílvia Busquets, Britta Stemmler, Francisco J López-Soriano. Nat Rev Cancer 2014
629
16

Common risk factors for heart failure and cancer.
Wouter C Meijers, Rudolf A de Boer. Cardiovasc Res 2019
89
16

Myocardial infarction accelerates breast cancer via innate immune reprogramming.
Graeme J Koelwyn, Alexandra A C Newman, Milessa S Afonso, Coen van Solingen, Emma M Corr, Emily J Brown, Kathleen B Albers, Naoko Yamaguchi, Deven Narke, Martin Schlegel,[...]. Nat Med 2020
61
16

Comprehensive quantification of fuel use by the failing and nonfailing human heart.
Danielle Murashige, Cholsoon Jang, Michael Neinast, Jonathan J Edwards, Alexis Cowan, Matthew C Hyman, Joshua D Rabinowitz, David S Frankel, Zolt Arany. Science 2020
95
16

A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.
F J Giordano, H P Gerber, S P Williams, N VanBruggen, S Bunting, P Ruiz-Lozano, Y Gu, A K Nath, Y Huang, R Hickey,[...]. Proc Natl Acad Sci U S A 2001
278
16

Oncometabolite d-2-hydroxyglutarate impairs α-ketoglutarate dehydrogenase and contractile function in rodent heart.
Anja Karlstaedt, Xiaotian Zhang, Heidi Vitrac, Romain Harmancey, Hernan Vasquez, Jing Han Wang, Margaret A Goodell, Heinrich Taegtmeyer. Proc Natl Acad Sci U S A 2016
74
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.